-
1
-
2
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study
Published 2022“…<p>Coronavirus disease 2019 (COVID-19) increases the risk of coagulopathy. Although the presence of antiphospholipid antibodies (aPLs) has been proposed as a possible mechanism of COVID-19-induced coagulopathy, its clinical significance remains uncertain. …”
-
3
-
4
-
5
Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
Published 2016“…<p dir="ltr">Increased levels of myeloid cells, especially myeloid-derived suppressor cells (MDSCs), have been reported to correlate with bad prognosis and reduced survival in cancer patients. …”
-
6
Cardiovascular autonomic neuropathy is associated with increased glycemic variability driven by hyperglycemia rather than hypoglycemia in patients with diabetes
Published 2023“…The percentage GRADEEuglycemia (3.30 ± 2.78 vs. 5.69 ± 3.09, P = 0.017) and GRADEHypoglycemia (0.3 (range: 0 – 3.80) vs. 1.8 (range: 0.9–6.5), P = 0.036) were significantly lower, while the percentage median GRADEHyperglycemia (95.45 (range:93–98) vs. 91.6 (82.8–95.1), P = 0.013) was significantly higher in participants with CAN compared to those without CAN.…”
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Contribution of Clinical Education in Developing Clinical Reasoning Skills of Undergraduate Physiotherapy Students in Preparation for Professional Practice in the United Arab Emira...
Published 2019“…Quantitative data analysis showed no significant difference in students’ self-assessment of clinical reasoning. …”
Get full text
-
16
-
17
-
18
Pioglitazone Effect on Clinical Outcome and Inflammatory Response in patients with type 2 diabetes mellitus and COVID-19: A Randomized Clinical Trial
Published 2024“…Twenty-eight participants met the primary clinical composite outcome. There was no significant difference in the incidence of primary outcome between subjects receiving placebo (n=14) and pioglitazone (n=14). …”
-
19
-
20